Since patients with CD4 counts under 200 cells/mm3 appear to be at a higher risk of relapse, earlier diagnosis of HIV infection, specific biomarkers of relapse, and the development of improved treatment regimens and options for secondary prophylaxis are urgently needed. The gene discussed is CD4; the disease is HIV infectious disease.